[1] Watt SM, Athanassopoulos A, Harris AL,et al. Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. J R Soc Interface. 2010; 7 Suppl 6: S731-51.[2] Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med. 2009;15(4):180-189.[3] Tongers J, Roncalli JG, Losordo DW. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res. 2010;79(3):200-206.[4] Hung HS, Shyu WC, Tsai CH,et al. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Cell Transplant. 2009;18(9):1003-1012.[5] Khoo CP, Pozzilli P, Alison MR. Endothelial progenitor cells and their potential therapeutic applications. Regen Med. 2008; 3(6):863-876.[6] Rodriguez-Losada N, Garcia-Pinilla JM, Jimenez-Navarro MF, et al. Endothelial progenitor cells in cell-based therapy for cardiovascular disease. Cell Mol Biol (Noisy-le-grand). 2008; 54(1):11-23.[7] Goldschmidt-Clermont PJ, Seo DM, Wang L, et al. Inflammation, stem cells and atherosclerosis genetics. Curr Opin Mol Ther. 2010;12(6):712-723.[8] Lam CF, Roan JN, Lee CH, et al. Transplantation of endothelial progenitor cells improves pulmonary endothelial function and gas exchange in rabbits with endotoxin-induced acute lung injury. Anesth Analg. 2011;112(3):620-627.[9] Cao JP, He XY, Xu HT,et al. Autologous transplantation of peripheral blood-derived circulating endothelial progenitor cells attenuates endotoxin-induced acute lung injury in rabbits by direct endothelial repair and indirect immunomodulation. Anesthesiology. 2012;116(6):1278-1287.[10] Lam CF, Liu YC, Hsu JK, et al. Autologous transplantation of endothelial progenitor cells attenuates acute lung injury in rabbits. Anesthesiology. 2008;108(3):392-401.[11] Gao X, Chen W, Liang Z,et al. Autotransplantation of circulating endothelial progenitor cells protects against lipopolysaccharide-induced acute lung injury in rabbit. Int Immunopharmacol. 2011;11(10):1584-1590.[12] Mao M, Wang Y, Hu DM, et al. Zhongguo Jijiu Yixue Zazhi. 2010;30(9):814-817. 毛梅,王艺,胡冬明,等. 内皮祖细胞移植对急性肺损伤大鼠肺组织内皮素的影响[J].中国急救医学杂志,2010,30(9):814-817.[13] Mikawa K, Nishina K, Takao Y, et al. ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung in rabbits. Thorax. 2003;97(6):1751-1755.[14] Yamada M, Kubo H, Ishizawa K, et al. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax.2005;60(5):410-413.[15] Rafat N, Hanusch C, Brinkkoetter PT, et al. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med.2007;35(7): 1677-1684.[16] Burnham EL, Taylor WR, Quyyumi AA, et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med. 2005;172(7):854-860.[17] Alev C, Ii M, Asahara T. Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid Redox Signal. 2011; 15: 949-965.[18] Borges VM, Vandivier RW, McPhillips KA, et al. TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. Am J Physiol Lung Cell Mol Physiol. 2009;297(4):L586-595.[19] Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. 2004;202(2):145-156.[20] Goodman RB, Pugin J, Lee JS, et al. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14(6):523-535. |